Recent observations in preclinical breast cancer models suggest that FTH1 is a significant tumor suppressor by inhibiting the expression of key oncogenes, such as c-MYC, and that its increased expression signifies a favorable prognosis and response to chemotherapy [24]. The gene discussed is MYC; the disease is breast carcinoma.